Maharashtra's COVID-19 curbs slowed spread of virus; stricter lockdown may not be needed, says Uddhav Thackeray

-

The existing COVID-19-related restrictions in Maharashtra have slowed down the rise in cases, and a stricter lockdown may not be needed, said Chief Minister Uddhav Thackeray in an address to the state.

He said Maharashtra would have seen nine to 10 lakh active coronavirus cases if the state government had not imposed new lockdown-like restrictions.

The latest restrictions helped contain the daily spike in coronavirus cases and active cases have now stabilised at around 6.5 lakh, Thackeray said on the eve of Maharashtra’s Foundation Day said. “We will fight this coronavirus wave together like we did last year," he added.

On the vaccination process, Thackeray said, "I promise you that our government will fulfil its responsibility of vaccinating those in the 18 to 44 years age group. So, please do not crowd vaccination centres."

"We are talking to the Serum Institute, Bharat Biotech and also the manufacturer of Russian vaccine Sputnik. We have been told by the Centre that we will get 18 lakh vaccines in Mayfor the 18-44 group out of which three lakh doses have been received," he said.

Vaccine doses for the 18-44 age group will be administered as per availability and people should not crowd vaccination centres, he said.

"Register and then go to take the vaccine, otherwise I fear the centres may become COVID-spreaders," he said.

His government had prepared for a second wave of the pandemic but did not realise it would be so ferocious, Thackeray said.

"We are gearing up to tackle a third wave which is expected in June-July," he said.

Thackeray also demanded that every state be allowed to develop its own app for the registration of people for COVID- 19 vaccination.

Currently, people have to register to receive a COVID-19 vaccine jab through the Co-WIN app of the Centre.

"All states should be allowed to develop their own apps for registration....the state apps can be linked to the main Co-WIN app and this will help streamline the registration process and stop crowding at vaccination centres," the Maharashtra chief minister said.

With inputs from PTI



from Firstpost India Latest News https://ift.tt/3u9Gbt0
FP Staff

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more